BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20877368)

  • 1. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
    J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Xu-hong Y; Falagas ME; Dong W; Karageorgopoulos DE; De-feng L; Rui W
    J Antibiot (Tokyo); 2014 May; 67(5):369-71. PubMed ID: 24517925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
    Aktas G; Derbentli S
    J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN; Mendes RE; Sader HS; Castanheira M
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
    Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
    Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the Antibacterial Synergistic Activity of Fosfomycin-Teicoplanin Combination in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Various Clinical Sample].
    Biçer RT; Özekinci T; Koçoğlu ME
    Mikrobiyol Bul; 2024 Apr; 58(2):113-124. PubMed ID: 38676580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
    Rebiahi SA; Abdelouahid DE; Rahmoun M; Abdelali S; Azzaoui H
    Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA; Castanheira M; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efforts to support the development of fusidic acid in the United States.
    Fernandes P; Pereira D
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus Isolated from Patients in a University Hospital in China from 2013 to 2015.
    Wu D; Chen Y; Sun L; Qu T; Wang H; Yu Y
    Jpn J Infect Dis; 2018 Jul; 71(4):312-314. PubMed ID: 29709971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.